The Structure of the MAP2K MEK6 Reveals an Autoinhibitory Dimer

Structure

Volumn 17, Issue 1, 2009, Pages 96-104

  Min, Xiaoshan ^a   Akella, Radha ^a   He, Haixia ^a   Humphreys, John M ^a   Tsutakawa, Susan E ^b   Lee, Seung Jae ^a   Tainer, John A ^b   Cobb, Melanie H ^a   Goldsmith, Elizabeth J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

PROTEINS; SIGNALING

Indexed keywords

ARGININE; ASPARTIC ACID; DIMER; MICROTUBULE ASSOCIATED PROTEIN 2; MITOGEN ACTIVATED PROTEIN KINASE KINASE 6; PHOSPHATE BINDING PROTEIN; PROTEIN SUBUNIT;

AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; CRYSTALLIZATION; CRYSTALLOGRAPHY; ENZYME PHOSPHORYLATION; ENZYME STRUCTURE; GEL FILTRATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION SCATTERING; WILD TYPE;

AMINO ACID SEQUENCE; ANIMALS; CRYSTALLOGRAPHY, X-RAY; DIMERIZATION; ENZYME ACTIVATION; HUMANS; MAP KINASE KINASE 1; MAP KINASE KINASE 6; MICE; MODELS, MOLECULAR; MOLECULAR MIMICRY; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROTEIN CONFORMATION; RATS; SCATTERING, RADIATION; SEQUENCE HOMOLOGY, AMINO ACID; SUBSTRATE SPECIFICITY;

EID: 58149201051     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.str.2008.11.007     Document Type: Article

References (64)

1. Bardwell L. Mechanisms of MAPK signalling specificity. Biochem. Soc. Trans. 34 (2006) 837-841
2. Bardwell A.J., Abdollahi M., and Bardwell L. Docking sites on mitogen-activated protein kinase (MAPK) kinases, MAPK phosphatases and the Elk-1 transcription factor compete for MAPK binding and are crucial for enzymic activity. Biochem. J. 370 (2003) 1077-1085
3. Bellon S., Fitzgibbon M.J., Fox T., Hsiao H.M., and Wilson K.P. The structure of phosphorylated p38γ is monomeric and reveals a conserved activation-loop conformation. Structure 7 (1999) 1057-1065
4. Biondi R.M., and Nebreda A.R. Signalling specificity of Ser/Thr protein kinases through docking-site-mediated interactions. Biochem. J. 372 (2003) 1-13
5. Braun S., Raymond W.E., and Racker E. Synthetic tyrosine polymers as substrates and inhibitors of tyrosine-specific protein kinases. J. Biol. Chem. 259 (1984) 2051-2054
6. Brunger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., Jiang J.S., Kuszewski J., Nilges M., Pannu N.S., et al. Crystallography & NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D Biol. Crystallogr. 54 (1998) 905-921
7. Canagarajah B.J., Khokhlatchev A., Cobb M.H., and Goldsmith E.J. Activation mechanism of the MAP kinase ERK2 by dual phosphorylation. Cell 90 (1997) 859-869
8. CCP4 (Collaborative Computing Project, Number 4). The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D Biol. Crystallogr. 50 (1994) 760-763
9. Chang C.I., Xu B.E., Akella R., Cobb M.H., and Goldsmith E.J. Crystal structures of MAP kinase p38 complexed to the docking sites on its nuclear substrate MEF2A and activator MKK3b. Mol. Cell 9 (2002) 1241-1249
10. Chen Z., Gibson T.B., Robinson F., Silvestro L., Pearson G., Xu B., Wright A., Vanderbilt C., and Cobb M.H. MAP kinases. Chem. Rev. 101 (2001) 2449-2476
11. DeLano W.L. The PyMOL Molecular Graphics System (2002), DeLano Scientific, San Carlos, CA
12. Deng Q., Liao R., Wu B.L., and Sun P. High intensity ras signaling induces premature senescence by activating p38 pathway in primary human fibroblasts. J. Biol. Chem. 279 (2004) 1050-1059
13. Dey M., Cao C., Dar A.C., Tamura T., Ozato K., Sicheri F., and Dever T.E. Mechanistic link between PKR dimerization, autophosphorylation, and eIF2α substrate recognition. Cell 122 (2005) 901-913
14. Doublie S., Xiang S., Gilmore C.J., and Carter Jr. C.W. Overcoming non-isomorphism by phase permutation and likelihood scoring: solution of the TrpRS crystal structure. Acta Crystallogr. A 50 (1994) 164-182
15. Enslen H., Brancho D.M., and Davis R.J. Molecular determinants that mediate selective activation of p38 MAP kinase isoforms. EMBO J. 19 (2000) 1301-1311
16. 2+ reveals a novel domain association. Biochemistry 46 (2007) 13041-13048
17. Goldsmith E.J., Akella R., Min X., Zhou T., and Humphreys J.M. Substrate and docking interactions in serine/threonine protein kinases. Chem. Rev. 107 (2007) 5065-5081
18. Gribble F.M., Loussouarn G., Tucker S.J., Zhao C., Nichols C.G., and Ashcroft F.M. A novel method for measurement of submembrane ATP concentration. J. Biol. Chem. 275 (2000) 30046-30049
19. Han J., Lee J.D., Jiang Y., Li Z., Feng L., and Ulevitch R.J. Characterization of the structure and function of a novel MAP kinase kinase (MKK6). J. Biol. Chem. 271 (1996) 2886-2891
20. Haystead T.A., Dent P., Wu J., Haystead C.M., and Sturgill T.W. Ordered phosphorylation of p42mapk by MAP kinase kinase. FEBS Lett. 306 (1992) 17-22
21. Heo Y.S., Kim S.K., Seo C.I., Kim Y.K., Sung B.J., Lee H.S., Lee J.I., Park S.Y., Kim J.H., Hwang K.Y., et al. Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125. EMBO J. 23 (2004) 2185-2195
22. Huang W., Kessler D.S., and Erikson R.L. Biochemical and biological analysis of Mek1 phosphorylation site mutants. Mol. Biol. Cell 6 (1995) 237-245
23. Hubbard S.R. Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog. EMBO J. 16 (1997) 5572-5581
24. Huse M., and Kuriyan J. The conformational plasticity of protein kinases. Cell 109 (2002) 275-282
25. Johnson G.L., and Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298 (2002) 1911-1912
26. Jones T.A., Zou J.Y., Cowan S.W., and Kjeldgaard M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47 (1991) 110-119
27. Jones G., Willett P., Glen R.C., Leach A.R., and Taylor R. Development and validation of a genetic algorithm for flexible docking. J. Mol. Biol. 267 (1997) 727-748
28. Knighton D.R., Zheng J., Ten Eyck L.F., Ashford V.A., Xuong N.-H., Taylor S.S., and Sowadski J.M. Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science 253 (1991) 407-413
29. Koch M.H., Vachette P., and Svergun D.I. Small-angle scattering: a view on the properties, structures and structural changes of biological macromolecules in solution. Q. Rev. Biophys. 36 (2003) 147-227
30. Lei M., Lu W., Meng W., Parrini M.C., Eck M.J., Mayer B.J., and Harrison S.C. Structure of PAK1 in an autoinhibited conformation reveals a multistage activation switch. Cell 102 (2000) 387-397
31. Leszczynski J.F., and Rose G.D. Loops in globular proteins: a novel category of secondary structure. Science 234 (1986) 849-855
32. Liu S., Sun J.P., Zhou B., and Zhang Z.Y. Structural basis of docking interactions between ERK2 and MAP kinase phosphatase 3. Proc. Natl. Acad. Sci. USA 103 (2006) 5326-5331
33. Magalhaes A., Maigret B., Hoflack J., Gomes J.N., and Scheraga H.A. Contribution of unusual arginine-arginine short-range interactions to stabilization and recognition in proteins. J. Protein Chem. 13 (1994) 195-215
34. Manning A.M., and Davis R.J. Targeting JNK for therapeutic benefit: from junk to gold?. Nat. Rev. Drug Discov. 2 (2003) 554-565
35. 2+ in human and ground squirrel red cells. J. Physiol. 470 (1993) 559-574
36. Murshudov G.N., Vagin A.A., and Dodson E.J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr. D Biol. Crystallogr. 53 (1997) 240-255
37. Nassar N., Horn G., Herrmann C., Scherer A., McCormick F., and Wittinghofer A. The 2.2 Å crystal structure of the Ras-binding domain of the serine/threonine kinase c-Raf1 in complex with Rap1A and a GTP analogue. Nature 375 (1995) 554-560
38. Ohren J.F., Chen H., Pavlovsky A., Whitehead C., Zhang E., Kuffa P., Yan C., McConnell P., Spessard C., Banotai C., et al. Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition. Nat. Struct. Mol. Biol. 11 (2004) 1192-1197
39. Otwinowski Z., and Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276 (1997) 307-326
40. Painter J., and Merritt E.A. Optimal description of a protein structure in terms of multiple groups undergoing TLS motion. Acta Crystallogr. D Biol. Crystallogr. 62 (2006) 439-450
41. Pearson G., Robinson F., Beers Gibson T., Xu B.E., Karandikar M., Berman K., and Cobb M.H. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 22 (2001) 153-183
42. Perrakis A., Morris R., and Lamzin V.S. Automated protein model building combined with iterative structure refinement. Nat. Struct. Biol. 6 (1999) 458-463
43. Putnam C.D., Hammel M., Hura G.L., and Tainer J.A. X-ray solution scattering (SAXS) combined with crystallography and computation: defining accurate macromolecular structures, conformations and assemblies in solution. Q. Rev. Biophys. 40 (2007) 191-285
44. Racker E. Use of synthetic amino acid polymers for assay of protein-tyrosine and protein-serine kinases. Methods Enzymol. 200 (1991) 107-111
45. Raman M., Chen W., and Cobb M.H. Differential regulation and properties of MAPKs. Oncogene 26 (2007) 3100-3112
46. Remenyi A., Good M.C., Bhattacharyya R.P., and Lim W.A. The role of docking interactions in mediating signaling input, output, and discrimination in the yeast MAPK network. Mol. Cell 20 (2005) 951-962
47. Schneider T.R., and Sheldrick G.M. Substructure solution with SHELXD. Acta Crystallogr. D Biol. Crystallogr. 58 (2002) 1772-1779
48. Sebolt-Leopold J.S., and English J.M. Mechanisms of drug inhibition of signalling molecules. Nature 441 (2006) 457-462
49. Sheffield P., Garrard S., and Derewenda Z. Overcoming expression and purification problems of RhoGDI using a family of parallel expression vectors. Protein Expr. Purif. 15 (1999) 34-39
50. Svergun D.I., Petoukhov M.V., and Koch M.H. Determination of domain structure of proteins from X-ray solution scattering. Biophys. J. 80 (2001) 2946-2953
51. Takekawa M., Tatebayashi K., and Saito H. Conserved docking site is essential for activation of mammalian MAP kinase kinases by specific MAP kinase kinase kinases. Mol. Cell 18 (2005) 295-306
52. Tanoue T., and Nishida E. Molecular recognitions in the MAP kinase cascades. Cell. Signal. 15 (2003) 455-462
53. Tsutakawa S.E., Hura G.L., Frankel K.A., Cooper P.K., and Tainer J.A. Structural analysis of flexible proteins in solution by small angle X-ray scattering combined with crystallography. J. Struct. Biol. 158 (2007) 214-223
54. Wan P.T., Garnett M.J., Roe S.M., Lee S., Niculescu-Duvaz D., Good V.M., Jones C.M., Marshall C.J., Springer C.J., Barford D., and Marais R. Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF. Cell 116 (2004) 855-867
55. Wang X., and Tournier C. Regulation of cellular functions by the ERK5 signalling pathway. Cell. Signal. 18 (2006) 753-760
56. Wang Z., Harkins P.C., Ulevitch R.J., Han J., Cobb M.H., and Goldsmith E.J. The structure of mitogen-activated protein kinase p38 at 2.1-Å resolution. Proc. Natl. Acad. Sci. USA 94 (1997) 2327-2332
57. Wrobleski S.T., and Doweyko A.M. Structural comparison of p38 inhibitor-protein complexes: a review of recent p38 inhibitors having unique binding interactions. Curr. Top. Med. Chem. 5 (2005) 1005-1016
58. Xie X., Gu Y., Fox T., Coll J.T., Fleming M.A., Markland W., Caron P.R., Wilson K.P., and Su M.S. Crystal structure of JNK3: a kinase implicated in neuronal apoptosis. Structure 6 (1998) 983-991
59. Yoon S., and Seger R. The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions. Growth Factors 24 (2006) 21-44
60. Zarubin T., and Han J. Activation and signaling of the p38 MAP kinase pathway. Cell Res. 15 (2005) 11-18
61. Zhang F., Strand A., Robbins D., Cobb M.H., and Goldsmith E.J. Atomic structure of the MAP kinase ERK2 at 2.3 Å resolution. Nature 367 (1994) 704-711
62. Zhang X., Gureasko J., Shen K., Cole P.A., and Kuriyan J. An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor. Cell 125 (2006) 1137-1149
63. Zhou T., Raman M., Gao Y., Earnest S., Chen Z., Machius M., Cobb M.H., and Goldsmith E.J. Crystal structure of the TAO2 kinase domain: activation and specificity of a Ste20p MAP3K. Structure 12 (2004) 1891-1900
64. Zhou T., Sun L., Humphreys J., and Goldsmith E.J. Docking interactions induce exposure of activation loop in the MAP kinase ERK2. Structure 14 (2006) 1011-1019